Association between serum HBV DNA levels and liver fibrosis in chronic hepatitis B
Digestive and Liver Disease · 2026
DOI: 10.1016/j.dld.2026.01.205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive and Liver Disease, 2026. Verfasst von Tao Fan und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Liver Cirrhosis, DNA, Viral, Hepatitis B virus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Southeast University, Jiangsu Province Natural Science Foundation, Jiangsu Commission of Health.
Abstract (Originalsprache)
BACKGROUND: The association between serum HBV DNA levels and liver fibrosis in patients with chronic hepatitis B (CHB) remains controversial. We investigated this association in non-cirrhotic CHB patients. METHODS: A total of 5,880 non-cirrhotic treatment-naïve CHB patients with ALT ≤2 × ULN were retrospectively included. Liver fibrosis was evaluated using FIB-4, APRI, LSM, or liver histology. RESULTS: The CHB patients had a median age of 38.0 years and 57.6% were male. There was a non-linear, parabolic association between serum HBV DNA loads and non-invasive fibrosis tests (APRI, FIB-4, and LSM). Patients with moderate serum HBV DNA levels (around 6 log10 IU/mL) had the highest APRI, FIB-4, and LSM values. After adjustment, the non-linear relationship between serum HBV DNA loads and non-invasive liver fibrosis indicators remained significant, especially in HBeAg-positive patients. Patients with moderate serum HBV DNA levels (around 6 log10 IU/mL) had the highest proportion of significant liver fibrosis as determined by APRI, FIB-4, LSM, and liver biopsy. CONCLUSIONS: A non-linear association was observed between serum HBV DNA levels and liver fibrosis in non-cirrhotic, treatment-naïve CHB patients with ALT ≤2 × ULN, with moderate HBV DNA levels (around 6 log₁₀ IU/mL) associated with a higher risk of fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
- Department of Infectious Diseases, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China; Institute of Viruses and Infectious Diseases, Nanjing University, Nanji…
- Department of Infectious Diseases, The Affiliated Infectious Diseases Hospital of Soochow University, Suzhou, Jiangsu, China.
- Department of Infectious Diseases, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
- Department of Infectious Diseases, Nanjing Drum Tower Hospital Clinical College of Jiangsu University, Nanjing, Jiangsu, China.
- Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, Jiangsu, China; Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanji…
Förderung
- Southeast University
- Jiangsu Province Natural Science Foundation
- Jiangsu Commission of Health
- National Key Research and Development Program of China
- Nanjing University
- National Natural Science Foundation of China
- Nanjing Medical Science and Technique Development Foundation
- Chinese Foundation for Hepatitis Prevention and Control
Zitieren
APA
Fan, T., Wang, J., Zhu, L., Xiong, Y., Zhang, S., Liu, J., Jiang, C., Yin, S., Tong, X., Wang, G., Jia, B., Xia, J., Yan, X., Yao, R., Chen, Y., Shi, Y., Liu, X., Qiu, Y., Geng, T., …, & Huang, R. (2026). Association between serum HBV DNA levels and liver fibrosis in chronic hepatitis B. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2026.01.205
Vancouver
Fan T, Wang J, Zhu L, Xiong Y, Zhang S, Liu J, et al. Association between serum HBV DNA levels and liver fibrosis in chronic hepatitis B. Digestive and Liver Disease. 2026. doi:10.1016/j.dld.2026.01.205
BibTeX
@article{Fan2026,
author = {Fan, Tao and Wang, Jian and Zhu, Li and Xiong, Ye and Zhang, Shaoqiu and Liu, Jiacheng and Jiang, Chao and Yin, Shengxia and Tong, Xin and Wang, Guiyang and Jia, Bei and Xia, Juan and Yan, Xiaomin and Yao, Renling and Chen, Yuxin and Shi, Yu and Liu, Xingxiang and Qiu, Yuanwang and Geng, Taoran and Zhang, Qun and Zhu, Chuanwu and Wu, Chao and Huang, Rui},
title = {Association between serum HBV DNA levels and liver fibrosis in chronic hepatitis B},
journal = {Digestive and Liver Disease},
year = {2026},
doi = {10.1016/j.dld.2026.01.205}
}
EUVIMED